InsidersTradesSigma
Follow the 三诺生物 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 三诺生物 has recorded 3 reports. Market capitalisation: €9bn. The latest transaction was filed on 5 May 2022 (Purchase). Among the most active insiders: 李心一. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
三诺生物 is a company focused on the health and pharmaceutical sector, specializing in the development of diagnostic and treatment products. It is listed on the XSHE market.